Okada, Kazuyoshi https://orcid.org/0009-0008-0725-2688
Tashiro, Manabu
Michiwaki, Hiroyuki
Yamaguchi, Sumiyo
Inoue, Tomoko
Kuragano, Takahiro https://orcid.org/0000-0001-6453-3824
Minakuchi, Jun
Article History
Received: 28 February 2025
Accepted: 12 June 2025
First Online: 1 August 2025
Declarations
:
: K.O., M.T., H.M., T.I., and J.M. received funding for specific clinical research (Japan Registry of Clinical Trials registration number jRCTs032220723) from Nipro Co., Ltd. and specific clinical research (Japan Registry of Clinical Trials with the registration number jRCTs062190020) from Asahi Kasei Medical Co., Ltd. K.O. reports personal fees from Kyowa Kirin Co., Ltd., Bayer Yakuhin, Ltd., Ono Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd., AstraZeneca Plc., Torii Pharmaceutical Co., Ltd., Sanwa Kagaku Kenkyusho Co., Kowa Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., and Eli Lilly Japan K.K. M. T. reports personal fees from Nippon Boehringer Ingelheim Co., Ltd., Eli Lilly Japan K.K., Toray Medical Co., Ltd., Novartis Pharm Co. Ldt., Otsuka Pharmaceutical Co., Ltd., Nova Biomedical Co., Ldt., and JMS Co. Ldt. H.M. reports personal fees from JMS Co. Ldt. and Fuso Pharmaceutical Industries, Ltd…T.I. reports personal fees from Nipro Co., Ltd., Kyowa Kirin Co., Ltd., AstraZeneca Plc., Torii Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Terumo Co. Ltd., JMS Co. Ldt., and Fuso Pharmaceutical Industries, Ltd. T.K. reports personal fees from Kyowa Kirin Co., Ltd., personal fees from Astellas Pharma Inc., personal fees from Bayer Yakuhin, Ltd., grants and personal fees from Ono Pharmaceutical Co., Ltd., grants from Kissei Pharmaceutical Co., Ltd., personal fees from Mitsubishi Tanabe Pharma Corporation, personal fees from Vantive Japan, personal fees from AstraZeneca Plc., personal fees from Torii Pharmaceutical Co., Ltd, personal fees from Sanwa Kagaku Kenkyusho Co., Ltd, and personal fees from Kaneka Medical products. J.M. reports personal fees from Kyowa Kirin Co., Ltd., Ono Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd., Vantive Japan, AstraZeneca Plc., Torii Pharmaceutical Co., Ltd., Sanwa Kagaku Kenkyusho Co., Nippon Boehringer Ingelheim Co., Ltd., Eli Lilly Japan K.K., Novartis Pharm Co. Ldt., Otsuka Pharmaceutical Co., Ltd., Chugai Parmaceutical Co., Ltd., Terumo Co. Ltd., and JMS Co. Ldt. S.Y. has no Conflict of Interest.